Abnormality of the dorsal column of the spinal cord
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent speech
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Alpers Syndrome (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Syndromic mitochondrial disorders obligatory associated with epilepsy include Alpers-Huttenlocher-syndrome (AHS), ataxia neuropathy spectrum (ANS), Leigh-syndrome, MELAS-syndrome, myoclonic epilepsy, myopathy, and sensory ataxia (MEMSA) syndrome, and MERRF-syndrome, Occasionally, epilepsy is a phenotypic feature in IOSCA, KSS, LHON, LBSL, or NARP, All types of seizures occur but most frequently generalized tonic-clonic seizures, partial seizures, myoclonic jerks, or West-syndrome was reported.
|
22459315 |
2012 |
Ataxia
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Our pathogenicity interpretation pathway predicted 13 different mutations in eight different genes: PRKCG, TTBK2, SETX, SPTBN2, SACS, MRE11, KCNC3 and DARS2 of which nine were novel including one causing a newly described recessive ataxia syndrome.
|
24030952 |
2013 |
Ataxia, Sensory
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Syndromic mitochondrial disorders obligatory associated with epilepsy include Alpers-Huttenlocher-syndrome (AHS), ataxia neuropathy spectrum (ANS), Leigh-syndrome, MELAS-syndrome, myoclonic epilepsy, myopathy, and sensory ataxia (MEMSA) syndrome, and MERRF-syndrome, Occasionally, epilepsy is a phenotypic feature in IOSCA, KSS, LHON, LBSL, or NARP, All types of seizures occur but most frequently generalized tonic-clonic seizures, partial seizures, myoclonic jerks, or West-syndrome was reported.
|
22459315 |
2012 |
Ataxia, Truncal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Babinski Reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
HBV suppresses NFAT5 through the miR-30e-5p/mitogen-activated protein kinase (MAPK) signaling pathway upstream of NFAT5 and inhibits the NFAT5 to enhance HCC tumorigenesis via the downstream target genes of DARS2.
|
29052520 |
2017 |
Central nervous system demyelination
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Cerebellar Ataxia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Our pathogenicity interpretation pathway predicted 13 different mutations in eight different genes: PRKCG, TTBK2, SETX, SPTBN2, SACS, MRE11, KCNC3 and DARS2 of which nine were novel including one causing a newly described recessive ataxia syndrome.
|
24030952 |
2013 |
Cerebellar atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebellar Dysmetria
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Cerebral atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral cortical atrophy
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Clumsiness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Clumsiness - motor delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital clubfoot
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
|
17463246 |
2007 |
Difficulty walking
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Difficulty walking
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Diplopia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Distal muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|